# Aligos Therapeutics, Inc.: Form 8-K, filed Feb 28, 2024

- Company: [Aligos Therapeutics, Inc.](/companies/algs.md) (CIK 1799448)
- Form: 8-K
- Filed: 2024-02-28
- Accepted by EDGAR: Feb 28, 2024, 17:28 ET
- Period: 2024-02-27
- Accession: 0001193125-24-050987
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1799448/000119312524050987/d766112d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1799448/000119312524050987/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1799448/000119312524050987/d766112d8k.htm

Filed Feb 28, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-050987. Last ingested by Listed: Nov 6, 2026, 12:13 ET. No prices; not investment advice.